“…marinum is widely used as a versatile M. tuberculosis infection model (Arafah et al, 2013;Bouz & Al Hasawi, 2018;Cardenal-Munoz, Barisch, Lefrancois, Lopez-Jimenez, & Soldati, 2017;Hagedorn, Rohde, Russell, & Soldati, 2009;Hagedorn & Soldati, 2007;Lienard & Carlsson, 2017;Prouty, Correa, Barker, Jagadeeswaran, & Klose, 2003;Shiloh & Champion, 2010;Tükenmez et al, 2019). M. marinum can be handled at biosafety Level 2 and is appreciated for its relatively rapid growth (doubling time of 4-10 hr vs. >20 hr for M. tuberculosis; Clark & Shepard, 1963), the M. tuberculosis-like behaviour during intracellular infection, such as replication within a distinct Mycobacterium-containing vacuole (MCV; Barker, George, Falkow, & Small, 1997;Pozos & Ramakrishnan, 2004;Smith et al, 2008;Tobin & Ramakrishnan, 2008;López-Jiménez et al, 2018;Koliwer-Brandl et al, 2019), as well as its wide spectrum of host cells including macrophages (Barker et al, 1997;Bouley, Ghori, Mercer, Falkow, & Ramakrishnan, 2001;Koliwer-Brandl et al, 2019;Ramakrishnan, Federspiel, & Falkow, 2000) and the amoeba Dictyostelium discoideum (Cardenal-Munoz et al, 2017;Hagedorn et al, 2009;Koliwer-Brandl et al, 2019;Solomon, Leung, & Isberg, 2003) or Acanthamoeba castellanii (Harrison et al, 2013;Kicka et al, 2014).…”